MedTrace Logo

Establishing Effects of Bacillus Clausii Probiotic Consumption on Gastrointestinal Health and Inflammation

NCT07618026 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2026-06-01

No results posted yet for this study

Summary

The study is a randomized, double-blind, crossover, placebo-controlled clinical intervention trial to test the effects of a commercial Bacillus (Shouchella) clausii probiotic compared to a placebo on gastrointestinal symptoms.

Conditions

  • Gastrointestinal Health

Interventions

DIETARY_SUPPLEMENT

Bacillus (Shouchella) clausii CSI08

Gram-positive, spore-forming microorganism

OTHER

Placebo

Inert filler material delivered in a capsule identical to the probiotic intervention

Sponsors & Collaborators

  • ADM Deerland

    collaborator UNKNOWN

  • Colorado State University

    lead OTHER

Principal Investigators

  • Tiffany L Weir, PhD · CSU

  • Allegra L Vazquez, MS · CSU

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-28
Primary Completion
2025-03-31
Completion
2025-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07618026 on ClinicalTrials.gov